Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, released its 2024 Annual Report including its Sustainability Statement. By ...

The healthcare company said it had sold around 3.6% of Fresenius Medical Care’s share capital and that it would use the ...

Fresenius SE is seeking to raise about €1.1 billion ($1.2 billion) in a sale of shares in Fresenius Medical Care AG as well ...

The US Supreme Court on Monday declined to review a Fresenius Kabi USA LLC scientist’s claim that she faced discrimination ...

The healthcare company issued a dividend for 2024 and forecast growth in earnings and sales for this year on higher ...

Dialysis firm Fresenius Medical Care shares fell 7.8% after German healthcare group Fresenius SE sold part of its stake in ...

In a report released today, Richard Felton from Goldman Sachs maintained a Buy rating on Fresenius Medical Care AG & Co. KGaA (0H9X – ...

The banker added: “Volatility will be higher for longer, and that can only help in the convertible space. The higher the ...

Fresenius, the German health care group, sold 3.6% of the shares in kidney dialysis provider Fresenius Medical Care on Monday ...

On March 7, 2025, the District Court for the District of New Jersey entered a Stipulation and Order of Dismissal Without Prejudice in view of ...

Erste Group reinstated coverage of Fresenius SE (FSNUY) with a Buy rating.Discover the Best Stocks and Maximize Your Portfolio: See what stocks ...

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi, an operating company of Fresenius, and Formycon AG, a leading, ...